Dr. Ronen Nazarian, MD

Dr. Nazarian practices at Camden Surgery Center in Beverly Hills, California.

Dr. Nazarian's NPI, 1194967141, was assigned on April 6, 2009. Dr. Nazarian graduated from Keck School of Medicine of USC in 2009. Dr. Nazarian holds California license A137944.

Dr. Nazarian's primary practice is Camden Surgery Center, at 414 N Camden Dr, Beverly Hills, CA 90210 in Los Angeles County. The practice phone is (310) 859-3991.

Dr. Nazarian's primary practice is Camden Surgery Center in Beverly Hills, California. Dr. Nazarian is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Center for Advanced Ear Surgery. Dmand AI also links Dr. Nazarian to 2 more group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nazarian practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Nazarian's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Nazarian is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Nazarian's licenses on file in 2 states: California and Florida.

Dmand AI lists acute sinusitis, chronic ear infection, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and swimmer's ear among the conditions Dr. Nazarian treats.

CMS data shows 2,244 Medicare services from Dr. Nazarian across 20 procedure codes in 2024, for 678 Medicare patients. Medicare paid $231,304 for them.

CMS counts 678 Medicare patients who saw Dr. Nazarian in 2024. The largest group is 75 to 84, with 279 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nazarian's median patient age at 68, with 52% women.

In 2024, Dr. Nazarian wrote 695 Medicare Part D claims for 273 patients. 94% of them were for generic drugs. CMS names the drug for 599 of them, across 17 drugs with 11 or more claims each, at $23,223 in total drug cost. In 2023, CMS named 371 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nazarian for performance year 2024, reported individually. Dr. Nazarian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nazarian as offering telehealth. CMS counts 22 procedures of removal of tissue by Dr. Nazarian, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Nazarian, published from 2005 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Cochlear Implantation, Cochlear Implants and Hearing. Dr. Nazarian has published most often in Otol Neurotol. Dr. Nazarian's most frequent co-authors are Adrien A. Eshraghi, MD, Fred F. Telischi, MD and Donald T. Weed, MD.

CMS Open Payments shows 80 general payments to Dr. Nazarian from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Cochlear Ltd paid the most, $605.

Dr. Nazarian graduated from Keck School of Medicine of USC in 2009.

Dr. Nazarian is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.